Sentences with phrase «additional common shares at»

If not all warrants are exercised, those warrant holders who exercise all of their warrants will be able to purchase additional common shares at the exercise price ($ 53) on a pro rata basis.

Not exact matches

HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their option to purchase additional shares, at a public offering price of $ 7.50 per share.

Bellicum expects to grant the underwriters of the offering a 30 - day option to purchase up to an additional 1,050,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions.

Cenovus has granted the underwriters an over-allotment option to purchase up to an additional 10.125 million common shares at the offering price for up to 30 days after closing.

To finance a portion of the cash consideration, Weston has agreed to subscribe for $ 500 million of additional Loblaw common shares at a price of $ 47.55 per share, Loblaw's closing share price on July 12, 2013.

Persons who have beneficially owned restricted shares of our common stock for at least six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three - month period only a number of securities that does not exceed the greater of either of the following:

In addition, based on the fair value of the shares of common stock of the Company at the time of issuance, the Company recorded an additional $ 100,000 of share based compensation expense related to the transaction.

Our principal stockholders, funds affiliated with or related to Cyrus Capital Partners, L.P. (which we refer to in this prospectus collectively as «Cyrus Capital») and affiliates of Virgin Group Holdings Limited (which we refer to in this prospectus collectively as the «Virgin Group»), as selling stockholders, have granted the underwriters an option to purchase up to additional shares of common stock at the initial public offering price less the underwriting discount solely to cover overallotments.

The Company has granted the Agents an over-allotment option, exercisable in whole or in part, for a period of 30 days following the closing of the Offering, to purchase up to an additional 4,726,500 Units at $ 3.65 per Unit, 4,726,500 Common Shares at the price of $ 3.62 per Share or 2,363,250 Warrants at the price of $ 0.06 per Warrant, or any combination thereof.

Each warrant will entitle the holder to acquire one additional common share of the Company at an exercise price of $ 0.08 until April 26, 2022 after the closing of the Offering.

Each Warrant is exercisable to acquire an additional common share of the Company at a price of $ 0.20 per share for a period of twenty - four months.

In addition, Dropbox has granted the underwriters a 30 - day option to purchase up to 5,400,000 additional shares of Class A common stock at the initial public offering price less underwriting discounts.

Debra at Common Ground shared her Neutral Winter Home Tour and an additional post where she goes into more detail about how she transitions from Christmas to neutral winter decor.

We purchased additional common shares of Kingstone Companies, Inc. (NASDAQ: KINS) in late January when the company raised capital in a follow - on offering at $ 12 per share.

Tallwood will also receive warrants to purchase an additional 7.8 million shares of common stock at $ 1.75 per share.

The warrants entitle the holder to purchase additional GYRO shares on the following terms; a warrant holder who exercises his / her warrants can purchase one common share of Gyrodyne at $ 53.00 for every 7.5 warrants exercised.

This is predicated not on selling your common stock positions during market declines, but on having the perseverance to use these inevitable sell - offs to purchase additional shares at lower prices.

At closing OXGN will place an additional 8.5 M shares of common stock in escrow to be released to VXGN stockholders contingent upon certain events over the 2 year period following the closing.

Foley Hoag LLP congratulates client Applied Genetic Technologies Corporation (Nasdaq: AGTC) on the closing of its public offering of 2 million shares of its common stock, at the price of $ 15.00 per share, and the exercise in full by the underwriters of their option to purchase 300,000 additional shares of common stock.

Forward - looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward - looking information, including but not limited to: risks related to changes in cryptocurrency prices; the estimation of personnel and operating costs; general global markets and economic conditions; risks associated with uninsurable risks; risks associated with currency fluctuations; competition faced in securing experienced personnel with appropriate industry experience and expertise; risks associated with changes in the financial auditing and corporate governance standards applicable to cryptocurrencies and ICO's; risks related to potential conflicts of interest; the reliance on key personnel; financing, capitalization and liquidity risks including the risk that the financing necessary to fund continued development of the Company's business plan may not be available on satisfactory terms, or at all; the risk of potential dilution through the issuance of additional common shares of the Company; the risk of litigation.

The Company has also granted the underwriters a 30 - day over-allotment option to purchase up to an additional 1,200,000 common shares of the Company at the Offering Price.